TLD 1433 Patent expiry July, 2034Can anyone comment, assuming we get the go ahead in 2026/2027 from FDA. We would theoretically hold the patent rights for appprox 7 to 8 Years. Plus the possible 433 days extension. What are the chances that this treatment could become a Generic treatment. Would major Pharma/ Potential JV partners lose interest in view of the looming Patent expiry. My thoughts are it is going to be difficult to produce this drug for less money and market it as a Generic?? so that other pharma companies can administer using the PDT technology which is quickly becoming popular all over the world..